|
Volumn 67, Issue 2, 2004, Pages 304-321
|
Reproductive opportunities and regulatory challenges.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
BETA THALASSEMIA;
COMMODIFICATION;
DIRECTED TISSUE DONATION;
DONOR;
EMBRYO TRANSFER;
ETHICS;
FERTILIZATION IN VITRO;
GENETIC ENGINEERING;
GENETICS;
GENETICS AND REPRODUCTION;
GOVERNMENT REGULATION;
HISTOCOMPATIBILITY TEST;
HUMAN;
HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY;
LEGAL APPROACH;
LEGAL ASPECT;
LICENSING;
PARENTAL CONSENT;
PRENATAL DIAGNOSIS;
REPRODUCTION;
SIBLING;
UNITED KINGDOM;
GENETICS AND REPRODUCTION;
HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY;
LEGAL APPROACH;
BETA-THALASSEMIA;
COMMODIFICATION;
DIRECTED TISSUE DONATION;
EMBRYO TRANSFER;
FERTILIZATION IN VITRO;
GOVERNMENT REGULATION;
GREAT BRITAIN;
HISTOCOMPATIBILITY TESTING;
HUMANS;
LICENSURE;
PARENTAL CONSENT;
PREIMPLANTATION DIAGNOSIS;
REPRODUCTION;
SEX PRESELECTION;
SIBLINGS;
TISSUE DONORS;
|
EID: 18144369989
PISSN: 00267961
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1468-2230.2004.00488.x Document Type: Article |
Times cited : (20)
|
References (0)
|